Company: PSTV
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0000950170-25-108874
Chunk: 0

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 1
Chunk 0
---
PLUS THERAPEUTICS, INC. 

 CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

(in thousands, except share and par value data)

     June 30, 2025

     December 31, 2024

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     2,233

     $
     76

     Investments

     4,646

     3,530

     Grant receivable

     1,021

     571

     Other current assets

     1,314

     1,082

     Total current assets

     9,214

     5,259

     Property and equipment, net

     289

     448

     Operating lease right-use-of assets

     29

     73

     Goodwill

     372

     372

     Intangible assets, net

     401

     469

     Other assets

     45

     12

     Total assets
      
     $
     10,350

     $
     6,633

     Liabilities and Stockholders’ Equity (Deficit)

     Current liabilities:

     Accounts payable and accrued expenses
      
     $
     6,359

     $
     11,288

     Operating lease liability

     30

     44

     Deferred grant liability

     927

     927

     Line of credit

     —

     3,292

     Total current liabilities

     7,316

     15,551

     Noncurrent operating lease liability

     —

     31

     Total liabilities

     7,316

     15,582

     Commitments and contingencies (Note 7)

     Stockholders’ equity (deficit):

     Preferred stock, $0.001 par value; 5,000,000 shares authorized; 1,952 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively

     —

     —

     Common stock, $0.001 par value; 2,000,000,000 shares authorized; 92,438,432 shares issued; and 92,180,007 shares outstanding as of June 30, 2025, and 100,000,00 shares authorized; 6,154,758